Nexalin Technology (NXL) Interest Expenses (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Interest Expenses of -$34.0 in Q1 2026, up 78.62% quarter-over-quarter from -$159.0 in Q4 2025, and up 96.92% on a YoY basis from -$17.27 in Q1 2025.
Nexalin Technology (NXL) Interest Expenses (2021 - 2026) Analysis & Trends
Nexalin Technology's Interest Expenses history runs 6 years deep, the most recent figure standing at -$34.0 for Q1 2026.
- In Q1 2026, Interest Expenses rose 96.92% year-over-year to -$34.0; the TTM figure through Mar 2026 stood at -$7171.0 (down 79.63% YoY), while the FY2025 annual figure was -$8240.0, down 158.06% from the prior year.
- Interest Expenses was -$34.0 for Q1 2026 at Nexalin Technology, up from -$159.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $19150.0 in Q4 2023 to a low of -$4690.0 in Q2 2025.
- Historically, Interest Expenses has averaged $4340.5 across 5 years, with a median of -$50.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Interest Expenses plunged 7006.06% in 2025, then surged 96.92% in 2026.
- A 5-year view of Interest Expenses shows it stood at $13496.0 in 2022, then soared by 41.89% to $19150.0 in 2023, then tumbled by 109.52% to -$1823.0 in 2024, then soared by 91.28% to -$159.0 in 2025, then jumped by 78.62% to -$34.0 in 2026.
- The last three Interest Expenses figures came in at -$34.0 (Q1 2026), -$159.0 (Q4 2025), and -$2288.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | -34.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.00 |
| Mar 31, 2026 | -34.00 |
| Dec 31, 2025 | -159.00 |
| Dec 31, 2025 | -159.00 |
| Sep 30, 2025 | -2,288.00 |
| Sep 30, 2025 | -2,288.00 |
| Jun 30, 2025 | -4,690.00 |
| Jun 30, 2025 | -4,690.00 |
| Mar 31, 2025 | -1,103.00 |
| Mar 31, 2025 | -1,103.00 |
| Dec 31, 2024 | -1,823.00 |
| Dec 31, 2024 | -1,823.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -66.00 |
| Jun 30, 2024 | -66.00 |
| Mar 31, 2024 | -304.00 |
| Mar 31, 2024 | -304.00 |
| Dec 31, 2023 | 19,150.00 |
| Dec 31, 2023 | 19,150.00 |